Emergency transapical mitral valve-in-valve implantation for bioprosthesis failure: transapical implantation of an Edwards Sapien-XT in a dysfunctional mitral bioprosthesis in a critical patient [PDF]
Background Valve-in-Valve (VIV) Transcatheter Aortic Valve Replacement (TAVR) is now the treatment of choice in high-surgical-risk patients with failing aortic bioprosthesis. Although less performed, VIV-Transcatheter Mitral Valve Replacement (TMVR) is a
Marco Zanobini +7 more
doaj +2 more sources
Perceval sutureless bioprosthesis versus Trifecta sutured bioprosthesis for aortic valve replacement: immediate results of the Perfecta study [PDF]
introduction: the perceval sutureless biological prosthesis for aortic valve replacement has been introduced with the rationale for shortening surgical, extracorporeal circulation and aortic cross-clamping times, in order to reduce postoperative ...
Paolo Nardi +10 more
doaj +2 more sources
Valve-shaped thrombus underneath an aortic bioprosthesis [PDF]
We describe massive thrombus formation completely occluding an aortic bioprosthesis in a patient with venoarterial extracorporeal membrane oxygenation and apical venting. The thrombus was surgically removed and the patient recovered with no complications.
Cibin G. +14 more
core +1 more source
Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis [PDF]
The ATS 3f Enable® Bioprosthesis is a self-expanding valve with a tubular design that allows for decreased leaflet stress and preservation of aortic sinuses. We report the midterm results of a prospective, multicenter clinical study evaluating the safety
Thierry Carrel +30 more
core +3 more sources
Platelet Reduction after Aortic Bioprosthesis Implantation:Results from the PORTRAIT Study [PDF]
: Platelet count reduction (PR) is a common but unclear phenomenon that occurs after aortic bioprosthesis valve implantation (bio-AVR). This study aimed to investigate the occurrence and clinical impact of PR in patients receiving stented, rapid ...
Jiritano, Federica +37 more
core +1 more source
Experimental Study and Early Clinical Application Of a Sutureless Aortic Bioprosthesis
INTRODUCTION: The conventional aortic valve replacement is the treatment of choice for symptomatic severe aortic stenosis. Transcatheter technique is a viable alternative with promising results for inoperable patients.
Walter J. Gomes +7 more
doaj +1 more source
Pulsed Cavitational Ultrasound Softening
The authors propose a novel noninvasive therapeutic approach for degenerative calcified bioprosthetic heart valves based on pulsed cavitational ultrasound (PCU) to improve the valvular function by remotely softening calcified stiff cusps. This study aims
Olivier Villemain, MD +9 more
doaj +1 more source
EARLY DEGENERATED BIOPROSTHETIC MITRAL VALVE [PDF]
Mitral valve prolapse (MVP) is fairly common in children, often being randomly found in asymptomatic, as well as in symptomatic patients with conjunctive tissue diseases (CTD). The authors report the case of an 11-yearold girl, diagnosed at the age of 6
Irina-Mihaela Ciomaga +5 more
doaj +1 more source
BA lloon Expandable vs. SElf Expanding Transcatheter VaLve for Degenerated BioprosthesIs: Design and Rationale of the BASELINE Trial. [PDF]
BACKGROUND Surgical aortic valve bioprostheses may degenerate over time and require redo intervention. Transcatheter aortic valve replacement (TAVR) is a less invasive alternative to redo surgery. The BAlloon Expandable vs.
Mascherbauer, Julia +36 more
core +2 more sources
Aortic Valve Replacement with a Conventional Stented Bioprosthesis versus Sutureless Bioprosthesis: a Study of 763 Patients [PDF]
Objective: The aim of this retrospective study was to compare early postoperative outcomes after aortic valve replacement (AVR) with sutureless bioprostheses and conventional stented bioprostheses implanted through median sternotomy.
Shah, Asif Raza +23 more
core +1 more source

